Sfoglia per Autore
Mutations of hMLH1 and hMSH2 in patients with suspected hereditary nonpolyposis colorectal cancer: correlation with microsatellite instability and abnormalities of mismatch repair protein expression
2002 M. Scartozzi, F. Bianchi, S. Rosati, E. Galizia, A. Antolini, C. Loretelli, A. Piga, I. Bearzi, R. Cellerino, E. Porfiri
'Secrets and lies' : the difficulties of communicating within families with inherited cancer syndromes
2004 F. Bianchi, S. Rosati, L. Belvederesi, C. Loretelli, B. Ferretti, I. Bearzi, A. Piga, R. Cellerino, E. Porfiri
MSH2 splice site mutation and endometrial cancer
2006 F. Bianchi, S. Rosati, L. Belvederesi, C. Loretelli, R. Catalani, A. Mandolesi, R. Bracci, I. Bearzi, E. Porfiri, R. Cellerino
Assessing the pathogenicity of MLH1 missense mutations in patients with suspected hereditary nonpolyposis colorectal cancer: Correlation with clinical, genetic and functional features
2006 L. Belvederesi, F. Bianchi, C. Loretelli, D. Gagliardini, E. Galizia, R. Bracci, S. Rosati, I. Bearzi, A. Viel, R. Cellerino, E. Porfiri
A missense germline mutation in exon 7 of the MSH2 gene in a HNPCC family from center-Italy
2007 F. Bianchi, E. Galizia, E. Porfiri, L. Belvederesi, R. Catalani, C. Loretelli, R. Bracci, I. Bearzi, C. Turchi, A. Viel, R. Cellerino
Effectiveness of the CRCAPRO program in identifying patients suspected for HNPCC
2007 F. Bianchi, E. Galizia, R. Bracci, L. Belvederesi, R. Catalani, C. Loretelli, G. Giorgetti, C. Ferretti, I. Bearzi, E. Porfiri, R. Cellerino
MSH2 missense mutations and HNPCC syndrome: Pathogenicity assessment in a human expression system
2008 L. Belvederesi, F. Bianchi, E. Galizia, C. Loretelli, R. Bracci, R. Catalani, M. Amati, R. Cellerino
Anidulafungin in combination with amphotericin B against Aspergillus fumigatus
2009 E. Spreghini, F. Orlando, A. Santinelli, E. Pisa, C. Loretelli, E. Manso, M.E. Milici, G. Scalise, F. Barchiesi
Epidermal growth factor receptor gene promoter methylation in primary colorectal tumors and corresponding metastatic sites : a new perspective for an "old" therapeutic target
2009 M. Scartozzi, I. Bearzi, A. Mandolesi, E. Galizia, C. Pierantoni, F. Loupakis, R. Berardi, A. Zaniboni, A. Quadri, F. Zorzi, S. Biagetti, C. Loretelli, T. Biscotti, R. Labianca, G. Masi, A. Falcone, S. Cascinu
BRCA1 expression in triple negative sporadic breast cancers
2010 E. Galizia, G. Giorgetti, G. Piccinini, A. Santinelli, C. Loretelli, F. Bianchi, D. Gagliardini, G. Carbonari, E. Pisa, L. Belvederesi, R. Bracci, C. Ferretti, F. Corradini, R. Cellerino
An intronic mutation in MLH1 associated with familial colon and breast cancer
2011 F. Bianchi, M. Raponi, F. Piva, A. Viel, I. Bearzi, E. Galizia, R. Bracci, L. Belvederesi, C. Loretelli, C. Brugiati, F. Corradini, D. Baralle, R. Cellerino
Allele polymorphisms of tumor integrins correlate with peritoneal carcinosis capability of gastric cancer cells in radically resected patients
2011 M. Scartozzi, C. Loretelli, I. Bearzi, A. Mandolesi, E. Galizia, A. Onofri, M. Pistelli, A. Bittoni, R. Berardi, S. Cascinu
Sub-cellular localization analysis of MSH6 missense mutations does not reveal an overt MSH6 nuclear transport impairment
2012 L. Belvederesi, F. Bianchi, C. Loretelli, R. Bracci, S. Cascinu, R. Cellerino
Phase II study of pharmacogenetic-tailored therapy in elderly colorectal cancer patients
2012 M. Scartozzi, C. Loretelli, R. Berardi, C. Pierantoni, R.R. Silva, D. Mari, R. Giampieri, L. Faloppi, M. Pistelli, E. Maccaroni, A. Bittoni, M. Del Prete, E. Galizia, S. Cascinu
Phosphorylated AKT and MAPK expression in primary tumours and in corresponding metastases and clinical outcome in colorectal cancer patients receiving irinotecan-cetuximab
2012 M. Scartozzi, R. Giampieri, E. Maccaroni, A. Mandolesi, S. Biagetti, S. Alfonsi, L. Giustini, C. Loretelli, L. Faloppi, A. Bittoni, M. Bianconi, M. Del Prete, I. Bearzi, S. Cascinu
Pre-treatment lactate dehydrogenase levels as predictor of efficacy of first-line bevacizumab-based therapy in metastatic colorectal cancer patients
2012 M. Scartozzi, R. Giampieri, E. Maccaroni, M. Del Prete, L. Faloppi, M. Bianconi, E. Galizia, C. Loretelli, L. Belvederesi, A. Bittoni, S. Cascinu
The role of LDH serum levels in predicting global outcome in HCC patients undergoing TACE : Implications for clinical management
2012 M. Scartozzi, L. Faloppi, M. Bianconi, R. Giampieri, E. Maccaroni, A. Bittoni, M. Del Prete, C. Loretelli, L. Belvederesi, G.S. Baroni, S. Cascinu
Role of vascular endothelial growth factor (VEGF) and VEGF-R genotyping in guiding the metastatic process in pT4a resected gastric cancer patients
2012 M. Scartozzi, C. Loretelli, E. Galizia, A. Mandolesi, M. Pistelli, A. Bittoni, R. Giampieri, L. Faloppi, M. Bianconi, M. Del Prete, F. Bianchi, L. Belvederesi, I. Bearzi, S. Cascinu
Tumor angiogenesis genotyping and efficacy of first-line chemotherapy in metastatic gastric cancer patients
2013 M. Scartozzi, R. Giampieri, C. Loretelli, A. Bittoni, A. Mandolesi, L. Faloppi, M. Bianconi, M. Del Prete, K. Andrikou, I. Bearzi, S. Cascinu
VEGF and VEGFR polymorphisms affect clinical outcome in advanced renal cell carcinoma patients receiving first-line sunitinib
2013 M. Scartozzi, M. Bianconi, L. Faloppi, C. Loretelli, A. Bittoni, M. Del Prete, R. Giampieri, E. Maccaroni, S. Nicoletti, L. Burattini, D. Minardi, G. Muzzonigro, R. Montironi, S. Cascinu
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile